Genomic Evidence on Antihypertensive Drug Targets and Oral Disease Outcomes

AIM: Antihypertensive medications are widely prescribed for hypertension, yet evidence regarding their oral health safety remains limited. We aimed to investigate whether genetically proxied pharmacological actions of antihypertensive drug classes influence the risk of periodontitis and dental caries using a two-sample drug-target Mendelian randomization framework. METHODS: Genetic instruments were obtained for 12 antihypertensive drug classes using variants within or near target genes associated with systolic blood pressure (SBP) in two genome-wide association study (GWAS) meta-analyses: one combining data from the International Consortium of Blood Pressure and UK Biobank, and another additionally including the Million Veteran Program (MVP) and Vanderbilt University's biorepository. Summary statistics for chronic periodontitis were obtained from the MVP GWAS, and for dental caries from the Gene-Lifestyle Interactions in Dental Endpoints consortium using the decayed, missing, and filled surfaces index. Causal effects were estimated using the inverse-variance weighted method with Benjamini-Hochberg correction for multiple testing. Colocalization analyses assessed whether drug targets and outcomes shared causal variants. RESULTS: Genetically proxied diazoxide acting through the KCNJ11 locus was associated with chronic periodontitis after multiple-testing correction (odds ratio [OR] per 1 mmHg lower SBP: 1.06, 95% confidence interval [CI]: 1.02-1.09), with consistent estimates after excluding variants associated with type 2 diabetes. No other associations were observed. Colocalization analyses provided no evidence of shared causal variants. CONCLUSION: We found little evidence that genetically proxied on-target pharmacological actions of antihypertensive drug classes were associated with periodontitis or dental caries. The diazoxide-periodontitis association should be interpreted with caution, given possible residual pleiotropy at the KCNJ11 locus and the absence of colocalization.

Authors

Institutions

Publication Details

Journal
Journal of Periodontal Research
Published
2026-06-28
DOI
https://doi.org/10.1111/jre.70143
Primary Topic
Genetic Associations and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genomic Evidence on Antihypertensive Drug Targets and Oral Disease Outcomes

Birte Holtfreter, Stefan Lars Reckelkamm, Michael Nolde, Zoheir Alayash et al.
Journal of Periodontal Research
Genetic Associations and Epidemiology
article

Genomic Evidence on Antihypertensive Drug Targets and Oral Disease Outcomes

Birte Holtfreter, Stefan Lars Reckelkamm, Michael Nolde, Zoheir Alayash, Thomas Kocher, Sebastian‐Edgar Baumeister, Ignacio Leiva‐Escobar, Aiswarya Puzhakkara Chennas
article en

Abstract

AIM: Antihypertensive medications are widely prescribed for hypertension, yet evidence regarding their oral health safety remains limited. We aimed to investigate whether genetically proxied pharmacological actions of antihypertensive drug classes influence the risk of periodontitis and dental caries using a two-sample drug-target Mendelian randomization framework. METHODS: Genetic instruments were obtained for 12 antihypertensive drug classes using variants within or near target genes associated with systolic blood pressure (SBP) in two genome-wide association study (GWAS) meta-analyses: one combining data from the International Consortium of Blood Pressure and UK Biobank, and another additionally including the Million Veteran Program (MVP) and Vanderbilt University's biorepository. Summary statistics for chronic periodontitis were obtained from the MVP GWAS, and for dental caries from the Gene-Lifestyle Interactions in Dental Endpoints consortium using the decayed, missing, and filled surfaces index. Causal effects were estimated using the inverse-variance weighted method with Benjamini-Hochberg correction for multiple testing. Colocalization analyses assessed whether drug targets and outcomes shared causal variants. RESULTS: Genetically proxied diazoxide acting through the KCNJ11 locus was associated with chronic periodontitis after multiple-testing correction (odds ratio [OR] per 1 mmHg lower SBP: 1.06, 95% confidence interval [CI]: 1.02-1.09), with consistent estimates after excluding variants associated with type 2 diabetes. No other associations were observed. Colocalization analyses provided no evidence of shared causal variants. CONCLUSION: We found little evidence that genetically proxied on-target pharmacological actions of antihypertensive drug classes were associated with periodontitis or dental caries. The diazoxide-periodontitis association should be interpreted with caution, given possible residual pleiotropy at the KCNJ11 locus and the absence of colocalization.

Journal of Periodontal Research
University of Münster (DE), Universitätsmedizin Greifswald (DE)
Good health and well-being
Openalex Percentile: Top 7%
Genetic Associations and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.